# Evaluating Endometriosis With 16α-(18)F-fluoro-17β-estradiol ([F-18] FES) PET/MRI

> **NCT04347135** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Annie (Annie) T. Packard**

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** F-18 FES

## Key facts

- **NCT ID:** NCT04347135
- **Lead sponsor:** Annie (Annie) T. Packard
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-10-07
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No Enrollment
- **Last updated:** 2024-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04347135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04347135, "Evaluating Endometriosis With 16α-(18)F-fluoro-17β-estradiol ([F-18] FES) PET/MRI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04347135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*